The Chemical Imbalance Myth: What the Science Actually Says
For decades, millions of people have been handed the same explanation for their depression: your brain has a chemical imbalance. Specifically, you don't have enough serotonin. Take this medication and we'll fix it.
It's a clean story. It's also not true.
And the people who built that story knew it wasn't true.
Where the Chemical Imbalance Theory Came From
The chemical imbalance theory — the idea that depression is caused by low serotonin levels — was never proven as a scientific fact. It was a hypothesis. A working theory that emerged in the 1960s alongside the first antidepressants and gained momentum not because the evidence was strong but because it was useful.
Useful, specifically, to the pharmaceutical industry.
In the 1990s, when Prozac and its cousins hit the market, Eli Lilly and other drug companies launched one of the most successful marketing campaigns in medical history. Direct-to-consumer pharmaceutical advertising — legal in only two countries in the world, the United States and New Zealand — told millions of Americans that they had a brain disease. The inference was that the sadness, the exhaustion, and the feeling that something was fundamentally wrong was actually a malfunction and deficiency. And, of course, it was something to be corrected with a pill.
The campaign worked. Antidepressant prescriptions skyrocketed. The chemical imbalance theory became cultural fact — something people repeated to their friends, their family members, their doctors. Something people used to understand themselves.
The science, meanwhile, told a different story.
What the Serotonin Research Actually Shows
The 2022 Umbrella Review That Changed Everything
In 2022, a comprehensive umbrella review led by researchers at University College London — one of the most thorough examinations of the serotonin theory ever conducted — reached a clear conclusion: there is no consistent evidence that depression is caused by low serotonin levels or reduced serotonin activity.
Not weak evidence. Not mixed evidence. No consistent evidence.
The researchers looked at every major area of serotonin research:
Molecular studies
Genetic studies
Studies of serotonin metabolites
Studies of serotonin receptors
Across all of them, the same finding: the theory doesn't hold up.
What Researchers Already Knew
This wasn't news to researchers. Many scientists and psychiatrists had been quietly skeptical for years — including Edward Bullmore, Cambridge psychiatrist and author of The Inflamed Mind, whose work has heavily influenced my work, as he examines inflammation as a far more credible driver of depression than serotonin deficiency. What was shocking was how wide the gap had grown between what the science knew and what the public had been told.
Thousands of people suffer from the side effects of antidepressants, including severe withdrawal when trying to stop. Many of them made the decision to start based on a belief that was never grounded in evidence.
The System Isn't Broken — It's Working Exactly as Designed
Here's the part that's hardest to sit with.
This isn't a story about science getting something wrong and then correcting itself. Science did its job. The researchers raised questions. The evidence was examined. The theory was found wanting.
Dr. Lisa Feldman Barrett, Professor of Psychology and one of the top 0.1% most cited scientists in the world, has been making this point from the neuroscience side for years. Serotonin isn't a mood chemical. It's a metabolic regulator and so is dopamine. The idea that you can isolate a single neurochemical, declare it deficient, and call that depression doesn't reflect how the brain actually works. Barrett's framework points to something far more complex: how the brain manages energy, predicts needs, and responds to chronic stress and metabolic disruption. Depression, in that model, isn't a shortage of anything. It's a system under strain.
What didn't happen was the public conversation. The same institutions that promoted the chemical imbalance narrative — pharmaceutical companies, mainstream media, even the American Psychiatric Association — never issued a correction. They quietly shifted their language, moving from "chemical imbalance" to "modulating brain chemistry" — close enough to carry the same implication, careful enough to avoid accountability.
What That Shift Cost Us
We are one of only two countries in the world where pharmaceutical companies can advertise directly to consumers. The result is a culture that has been sold a story about its own brain — and built an identity around it. We don't just have diagnoses anymore. We live them. We introduce ourselves by them. We organize our lives around managing them rather than understanding them.
The system wasn't broken. It was doing exactly what it was designed to do.
What the Chemical Imbalance Myth Actually Cost Us
None of this means that antidepressants don't help people. Some people experience real relief from medication and that experience is valid. The question isn't whether medication can be useful; it's whether the explanation we were given for why it works was accurate. Frankly, it wasn't.
Depression is real. It is embodied and it lives in:
The nervous system
The gut
The hormonal system
The patterns of thought and behavior that form over a lifetime
The biology is absolutely part of the picture.
What the chemical imbalance theory missed (and what it was structurally designed to miss) is that the biology is downstream of everything else. Downstream of chronic stress. Of unprocessed trauma. Of gut dysbiosis. Of nervous system dysregulation. Of the existential questions of meaning and identity that nobody in a white coat ever thought to ask.
Depression and anxiety are not malfunctions. They are intelligent responses from a whole system that has been overwhelmed, dismissed, or never properly understood.
What a Whole-System Approach to Depression Actually Looks Like
If the chemical imbalance theory is the wrong map, what's the right one?
The emerging science points toward something more complex and more hopeful. Depression is increasingly understood as heterogeneous — not one thing with one cause, but many things with many causes, all of them interconnected:
Inflammation
Gut health
Trauma
Nervous system dysregulation
Lifestyle and environment
The stories we inherited about who we are and what we deserve
Psychiatrist Kelly Brogan, M.D., covers much of this ground in A Mind of Your Own — one of the more accessible clinical arguments for why the current model is failing people.
Treating it requires looking at all of those things together, not in isolation, and certainly not through the lens of a single discipline that only sees its own piece of the picture.
This Is What My Work Is Built On
This is the argument at the heart of my doctoral research — The Great Misdiagnosis — and it's the premise behind every session I do. The REALIGN™ Framework is the structure I use to make sure nothing gets missed — root cause, nervous system, lifestyle, energetic patterns, and the deeper questions of identity and meaning that conventional treatment never gets to excavate.
The diagnosis isn't always wrong. It's just incomplete. And incomplete maps lead people in circles for years, sometimes decades, without ever getting to what's actually driving the suffering.
You deserve a better map.
Gina Ruccione is a transpersonal counselor, integrative wellness practitioner, and PhD candidate in transpersonal counseling. Her doctoral dissertation, The Great Misdiagnosis, examines why depression and anxiety are so frequently misunderstood — and what becomes possible when we look at the whole system.
If this resonates and you want to understand what's actually driving what you're experiencing, start with a free 20-minute consultation.
This post contains affiliate links. If you purchase through them, I may earn a small commission at no additional cost to you.
